Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673)-Reference-Cited by-同舟云学术

Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673)

Published:2004 Issue:8 Volume:100 Page:1692-1698
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Agarwala Sanjiv S.,Neuberg Donna,Park Yuhyun,Kirkwood John M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference16 articles.

1. ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMA

2. BCG lmmunotherapy of Malignant Melanoma

3. A randomized trial of adjuvant chemotherapy and immunotherapy in stage I and stage II cutaneous melanoma. An interim report

4. Adjuvant Immunotherapy or Chemotherapy for Malignant Melanoma: Preliminary Report of the National Cancer Institute Randomized Clinical Trial

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and emerging intralesional immunotherapies in cutaneous oncology;Journal of the American Academy of Dermatology;2024-06

2. Intralesional and Infusional Updates for Metastatic Melanoma;Cancers;2024-05-22

3. Efficacy of Bacillus Calmette-Guérin in Cancer Prevention and Its Putative Mechanisms;Journal of Cancer Prevention;2024-03-29

4. Oncolytic intralesional therapy for metastatic melanoma;Clinical & Experimental Metastasis;2023-08-09

5. Abscopal responses in patients with metastatic melanoma involving skin and subcutaneous tissues treated with intralesional IL2 plus BCG;Frontiers in Oncology;2023-04-27